A 22-year-old donor experienced heart problems at the site that led to her death

Canada one of eight countries targeted in agreements struck with Pfizer and Eli Lilly

Michael Green alleges he was scapegoated for failure of PrescribeIT, a project to get doctors to send prescriptions electronically

French pharmaceutical maker’s site is also designed to provide new capacity for vaccine production in event of another pandemic

The safety of drugs made from plasma has not been compromised, says Canadian Blood Services

Company’s plasma collection sites have been closed to donors since Aug. 14, two days after Health Canada delivered its most recent critical review

Few details have been released on the incidents, however Health Canada has accepted the new numbers

Private blood-plasma collector has been under scrutiny for months after the deaths of two donors

Department says growing backlog is largely due to sharp increase in submissions

Issues at a manufacturing plant in India have sidelined two competitors

Agency’s medical summary on young Winnipeg donor’s death was based on records from Grifols and Manitoba’s medical examiner

U.S. President plans to impose 100% levies on generic pharmaceuticals made abroad starting in 2028

Collector says no donor or patient was put at risk after inspection report outlined safety concerns

There is a push to reduce the demand for the plasma-derived therapy, as patients, physicians and governments worry about whether the growth is sustainable

Inspectors found multiple cases of the company allowing people to donate who should have been denied because of risks associated with a fatal brain disorder

Audit would be duplicative of government’s efforts and offer ‘limited added value for parliamentarians and Canadians,’ the A-G said

Graham Sher says he believes the private blood-plasma collector would fix deficiencies discovered by Health Canada

Program was launched in 2017 as part of ‘axe the fax’ initiatives to replace fax machines with digital alternatives

Florida was the first state to be approved for the program in 2024, but no drugs were actually shipped

Company began trading on the TSX last week and announced Tuesday it had completed its offering for gross proceeds of $1.495-billion

Health Minister Marjorie Michel says $50-million will remain withheld until the agency addresses governance concerns

Infoway says it supplied the majority of the documents on time, but the remainder cover a ‘broad range of historical records’ that could include hundreds of thousands of pages

Calls for more scrutiny of the circumstances surrounding the death at the for-profit donation centre came after the government’s initial report

Digital prescription program suffered from slow enrolment process, lack of national buy-in

Toronto company founded by the late Barry Sherman expected to become Canada’s most valuable public life sciences company

Toronto’s Apotex prices its version of Ozempic at less than a third of the cost of the brand-name product

Locations in Toronto and Cambridge haven’t been inspected since opening last year

Ontario NDP MPP says inspection system hasn’t adapted to rise in for-profit blood collection

Rodiyat Alabede, 22, died after donating plasma at a Grifols collection centre in Winnipeg

Two donors have died in recent months after giving plasma at Grifols’ clinics in Winnipeg

Document suggests federal health agency pointed out some of the same concerns repeatedly since 2022 without resolution

For years, Canadians weren’t paid for a prized medical resource in their veins. Now, some are

Pay was justified because it was on par with hospital executives, Peter Vaughan tells MPs

Apotex is first company to get approval that has domestic manufacturing presence

Failed program is under scrutiny for lack of uptake despite $300-million in federal funds spent

Dr. Reddy’s Laboratories Ltd. has been authorized to sell the drug, Health Canada says

PrescribeIT service that cost nearly $300-million in federal funds was cancelled in February after few doctors used it

Burlington clinic includes an optional membership plan for clients

CEO Michael Green struggled to provide satisfactory answers to questions about PrescribeIT’s budget

Non-binding recommendation comes with stipulation that Eli Lilly offer the drug at a discount

U.S. market will not open till patent expires in 2032, but individual generics can be sold in Canada once approved

Advocate calls for formal inquiry into company’s operations, citing concerns over Health Canada’s investigation of the deaths

Group plans to meet every two weeks and prepare a report in 90 days with options for Canada’s response

Regulator says Grifols centres must reduce number of appointments, better supervise new staff and improve donor records

VP tells House of Commons committee that donors are informed of risk of death during the procedure

Demand growing for immunoglobulin to address immune deficiencies that can result from cancer treatment

Generic versions of diabetes and weight-loss drug became legal in early January

Centralized record-keeping system would allow GPs to more easily access health care data

Health Canada says four such deaths have occurred in the last 10 years, as Manitoba mulls a ban on the practice

Grifols, which runs the centres, says it’s co-operating with the government and doing its own investigation